Distributions of antibody titers to Mycoplasma pneumoniae in Korean children in 2000-2003

Journal of Korean Medical Science

Volumn 20, Issue 4, 2005, Pages 542-547

  Yu, Jinho ^a   Yoo, Young ^b   Do, Kyun Kim ^c   Kang, Hee ^d   Young, Yull Koh ^c,e  

^a Dongguk University Ilsan Hospital   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Seoul National University   (South Korea)

^d Korea University College of Medicine   (South Korea)

^e Seoul National University Hospital   (South Korea)

Author keywords

Age; Atopy; Child; Disease Outbreaks; Korea; Mycoplasma pneumoniae; Serologic Tests; Sex

Indexed keywords

EID: 24644444853     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2005.20.4.542     Document Type: Article

References (37)

1. Atmar RL, Greenberg SB. Pneumonia caused by Mycoplasma pneumoniae and the TWAR agent. Semin Respir Infect 1989; 4: 19-31.
2. Lind K, Benzon MW, Jensen JS, Clyde WA Jr. A seroepidemiological study of Mycoplasma pneumoniae infections in Denmark over the 50-year period 1946-1995. Eur J Epidemiol 1997; 13: 581-6.
3. Foy HM, Kenny GE, Cooney MK, Allan ID. Long-term epidemiology of infections with Mycoplasma pneumoniae. J Infect Dis 1979; 139: 681-7.
4. Ito I, Ishida T, Osawa M, Arita M, Hashimoto T, Hongo T, Mishima M. Culturally verified Mycoplasma pneumoniae pneumonia in Japan: a long-term observation from 1979-99. Epidemiol Infect 2001; 127: 365-7.
5. Foy HM, Kenny GE, McMahan R, Mansy AM, Grayston JT. Mycoplasma pneumoniae pneumonia in an urban area. Five years of surveillance. JAMA 1970; 214: 1666-72.
6. Joosting AC, Harwin RM, Coppin A, Battaglia P, van der Hoef P. A serological investigation of Mycoplasma pneumoniae infection on the Witwatersrand. S Afr Med J 1976; 50: 2134-5.
7. Kang KS, Woo H. Pattern of occurrence of Mycoplasma pneumoniae pneumonia in admitted children: southern central Korea, from 1989 to 2002. J Korean Pediatr Soc 2003; 46: 474-9.
8. Park HY, Woo CW, Choung JT, Son CS, Tockgo YC. Trend of the Mycoplasma pneumonia: during recent 9 years period. Pediatr Allergy Respir Dis 1995; 5: 49-59.
9. Yoo HS, Kang HY, Jeoung BJ, Kim KE, Lee KY. A clinical study of Mycoplasma pneumoniae pneumonia. Pediatr Allergy Respir Dis 1995; 5: 112-22.
10. Hong JY, Nah SY, Nam SG, Choi EH, Park JY, Lee HJ. Occurrence of Mycoplasma pneumoniae pneumonia in Seoul, Korea, from 1986 to 1995. J Korean Pediatr Soc 1997; 40: 607-13.
11. Waris ME, Toikka P, Saarinen T, Nikkari S, Meurman O, Vainionpaa R, Mertsola J, Ruuskanen O. Diagnosis of Mycoplasma pneumoniae pneumonia in children. J Clin Microbiol 1998; 36: 3155-9.
12. Waites KB. New concepts of Mycoplasma pneumoniae infections in children. Pediatr Pulmonol 2003; 36: 267-78.
13. Daxboeck F, Krause R, Wenisch C. Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin Microbiol Infect 2003; 9: 263-73.
14. Rastawicki W, Kaluzewski S, Jagielski M. Occurrence of serologically verified Mycoplasma pneumoniae infections in Poland in 1970-1995. Eur J Epidemiol 1998; 14: 37-40.
15. Ponka A, Ukkonen P. Age-related prevalence of complement-fixing antibody to Mycoplasma pneumoniae during an 8-year period. J Clin Microbiol 1983; 17: 571-5.
16. Bosnak M, Dikici B, Bosnak V, Dogru O, Ozkan I, Ceylan A, Haspolat K. Prevalence of Mycoplasma pneumoniae in children in Diyarbakir, the south-east of Turkey. Pediatr Int 2002; 44: 510-2.
17. Barker CE, Sillis M, Wreghitt TG. Evaluation of Serodia Myco II particle agglutination test for detecting Mycoplasma pneumoniae antibody: comparison with mu-capture ELISA and indirect immunofluorescence. J Clin Pathol 1990; 43: 163-5.
18. Choi SK, Jung JA, Kim KH, Kim GH. Study of seroprevalence of antimycoplasma antibody in healthy children and its diagnostic value. J Korean Pediatr Soc 1998; 41: 489-97.
19. Host A, Andrae S, Charkin S, Diaz-Vazquez C, Dreborg S, Eigenmann PA, Friedrichs F, Grinsted P, Lack G, Meylan G, Miglioranzi P, Muraro A, Nieto A, Niggemann B, Pascual C, Pouech MG, Rance F, Rietschel E, Wickman M. Allergy testing in children: why, who, when and how? Allergy 2003; 58: 559-69.
20. Wittig HJ, Belloit J, De Fillippi I, Royal G. Age-related serum immunoglobulin E levels in healthy subjects and in patients with allergic disease. J Allergy Clin Immunol 1980; 66: 305-13.
21. Tang ML, Coleman J, Kemp AS. Interleukin-4 and interferon-gamma production in atopic and non-atopic children with asthma. Clin Exp Allergy 1995; 25: 515-21.
22. Foy HM, Kenny GE, Cooney MK, Allan ID, van Belle G. Naturally acquired immunity to pneumonia due to Mycoplasma pneumoniae. J Infect Dis 1983; 147: 967-73.
23. Foy HM, Kenny GE, Seri R, Ochs HD, Allan ID. Second attacks of pneumonia due to Mycoplasma pneumoniae. J Infect Dis 1977; 135: 673-7.
24. Biberfeld G. Antibody responses in Mycoplasma pneumoniae infection in relation to serum immunogloblins, especially IgM. Acta Pathol Microbiol Scand Sect B 1971; 79: 620-34.
25. Nakamura S, Ebisawa I, Kitamoto O, Sato T. Persistence of serum antibody following Mycoplasma pneumoniae infection. Am Rev Respir Dis 1970; 101: 620-2.
26. Broughton RA. Infections due to Mycoplasma pneumoniae in childhood. Pediatr Infect Dis 1986; 5: 71-85.
27. Lind K, Bentzon MW. Ten and a half years seroepidemiology of Mycoplasma pneumoniae infection in Denmark. Epidemiol Infect 1991; 107: 189-99.
28. Layani-Milon MP, Gras I, Valette M, Luciani J, Stagnara J, Aymard M, Lina B. Incidence of upper respiratory tract Mycoplasma pneumoniae infections among outpatients in Rhone-Alpes, France, during five successive winter periods. J Clin Microbiol 1999; 37: 1721-6.
29. Fernald GW, Collier AM, Clyde WA Jr. Respiratory infections due to Mycoplasma pneumoniae in infants and children. Pediatrics 1975; 55: 327-35.
30. Brunner H, Horswood RL, Chanock RM. More sensitive methods for detection of antibody to Mycoplasma pneumoniae. J Infect Dis 1973; 127 (Suppl): 52-5.
31. Dallo SF, Baseman JB. Intracellular DNA replication and long-term survival of pathogenic mycoplasmas. Microb Pathog 2000; 29: 301-9.
32. Radisic M, Torn A, Gutierrez P, Defranchi HA, Pardo P. Severe acute lung injury caused by Mycoplasma pneumoniae: potential role for steroid pulses in treatment. Clin Infect Dis 2000; 31: 1507-11.
33. Holtmann H, Shemer-Avni Y, Wessel K, Sarov I, Wallach D. Inhibition of growth of Chlamydia trachomatis by tumor necrosis factor is accompanied by increased prostaglandin synthesis. Infect Immun 1990; 58: 3168-72.
34. Williams DM, Magee DM, Bonewald LF, Smith JG, Bleicker CA, Byrne GI, Schachter J. A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis. Infect Immun 1990; 58: 1572-6.
35. Sher A, Coffman RL. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu Rev Immunol 1992; 10: 385-409.
36. Kaufman SH. Immunity to intracellular bacteria. Annu Rev Immunol 1993; 11: 129-63.
37. Ferrari M, Poli A, Olivieri M, Verlato G, Tardivo S, Nicolis M, Campello C. Respiratory symptoms, asthma, atopy and Chlamydia pneumoniae IgG antibodies in a general population sample of young adults. Infection 2002; 30: 203-7.